Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Pharmaceutical Design | journal | 0.586 Q2 | 183 | 316 | 1278 | 27228 | 3460 | 1174 | 2.55 | 86.16 | |
2 | Current Medicinal Chemistry | journal | 0.759 Q1 | 202 | 229 | 1117 | 25841 | 4143 | 1046 | 3.54 | 112.84 | |
3 | Current Neuropharmacology | journal | 1.299 Q1 | 103 | 177 | 379 | 22198 | 2240 | 363 | 4.96 | 125.41 | |
4 | Current Topics in Medicinal Chemistry | journal | 0.549 Q2 | 133 | 177 | 640 | 18576 | 1720 | 515 | 2.52 | 104.95 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.597 Q2 | 107 | 128 | 492 | 14236 | 1903 | 484 | 3.60 | 111.22 | |
6 | Current Organic Chemistry | journal | 0.314 Q3 | 112 | 148 | 389 | 13518 | 701 | 364 | 1.65 | 91.34 | |
7 | CNS and Neurological Disorders - Drug Targets | journal | 0.620 Q2 | 96 | 120 | 223 | 12672 | 632 | 207 | 2.79 | 105.60 | |
8 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.503 Q3 | 108 | 201 | 723 | 12531 | 2011 | 702 | 2.69 | 62.34 | |
9 | Combinatorial Chemistry and High Throughput Screening | journal | 0.301 Q3 | 70 | 215 | 504 | 12432 | 828 | 472 | 1.71 | 57.82 | |
10 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.495 Q3 | 63 | 177 | 557 | 10866 | 1227 | 539 | 2.06 | 61.39 | |
11 | Current Drug Targets | journal | 0.691 Q2 | 119 | 97 | 390 | 10001 | 1214 | 368 | 2.96 | 103.10 | |
12 | Letters in Drug Design and Discovery | journal | 0.222 Q3 | 37 | 172 | 329 | 9716 | 360 | 304 | 1.23 | 56.49 | |
13 | Current Drug Delivery | journal | 0.451 Q2 | 72 | 108 | 295 | 9600 | 813 | 284 | 2.63 | 88.89 | |
14 | Current Diabetes Reviews | journal | 0.765 Q2 | 68 | 105 | 306 | 8047 | 991 | 300 | 2.27 | 76.64 | |
15 | Current Stem Cell Research and Therapy | journal | 0.525 Q2 | 63 | 100 | 203 | 7644 | 476 | 194 | 2.12 | 76.44 | |
16 | Current Medical Imaging | journal | 0.288 Q3 | 37 | 184 | 517 | 7302 | 731 | 499 | 1.25 | 39.68 | |
17 | Current Nutrition and Food Science | journal | 0.219 Q3 | 32 | 99 | 359 | 7092 | 370 | 352 | 0.97 | 71.64 | |
18 | Current Molecular Pharmacology | journal | 0.540 Q3 | 49 | 72 | 209 | 6446 | 509 | 199 | 2.37 | 89.53 | |
19 | Emirates Journal of Food and Agriculture | journal | 0.254 Q3 | 43 | 132 | 334 | 6152 | 394 | 334 | 0.83 | 46.61 | |
20 | Current Protein and Peptide Science | journal | 0.527 Q2 | 96 | 69 | 252 | 5886 | 615 | 237 | 1.95 | 85.30 | |
21 | Current Nanoscience | journal | 0.267 Q3 | 52 | 74 | 228 | 5777 | 388 | 221 | 1.65 | 78.07 | |
22 | Letters in Organic Chemistry | journal | 0.174 Q4 | 33 | 123 | 375 | 5692 | 266 | 336 | 0.76 | 46.28 | |
23 | Current Bioactive Compounds | journal | 0.184 Q3 | 31 | 86 | 291 | 5575 | 253 | 282 | 0.82 | 64.83 | |
24 | Current Cancer Drug Targets | journal | 0.650 Q2 | 103 | 76 | 216 | 5127 | 602 | 211 | 2.34 | 67.46 | |
25 | Medicinal Chemistry | journal | 0.337 Q3 | 50 | 69 | 271 | 5094 | 609 | 265 | 2.05 | 73.83 | |
26 | Mini-Reviews in Organic Chemistry | journal | 0.327 Q3 | 43 | 50 | 197 | 4530 | 406 | 189 | 1.90 | 90.60 | |
27 | Current Cardiology Reviews | journal | 0.608 Q2 | 58 | 61 | 183 | 4509 | 414 | 169 | 2.23 | 73.92 | |
28 | Infectious Disorders - Drug Targets | journal | 0.338 Q3 | 61 | 89 | 374 | 4320 | 542 | 350 | 1.47 | 48.54 | |
29 | Open Dentistry Journal | journal | 0.186 Q3 | 37 | 104 | 311 | 4096 | 283 | 295 | 0.55 | 39.38 | |
30 | Current Analytical Chemistry | journal | 0.293 Q3 | 38 | 66 | 316 | 3972 | 539 | 295 | 1.59 | 60.18 | |
31 | Current Bioinformatics | journal | 0.383 Q3 | 38 | 66 | 321 | 3915 | 733 | 315 | 2.41 | 59.32 | |
32 | Current Pharmaceutical Analysis | journal | 0.184 Q3 | 27 | 63 | 339 | 3875 | 249 | 329 | 0.77 | 61.51 | |
33 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.540 Q2 | 52 | 41 | 103 | 3859 | 252 | 100 | 2.51 | 94.12 | |
34 | Current Alzheimer Research | journal | 0.584 Q3 | 103 | 60 | 306 | 3843 | 659 | 294 | 1.80 | 64.05 | |
35 | Recent Patents on Engineering | journal | 0.182 Q4 | 21 | 57 | 206 | 3794 | 131 | 188 | 0.69 | 66.56 | |
36 | Current Organic Synthesis | journal | 0.318 Q3 | 55 | 51 | 184 | 3705 | 355 | 159 | 1.93 | 72.65 | |
37 | Current Pediatric Reviews | journal | 0.601 Q2 | 33 | 49 | 108 | 3281 | 269 | 100 | 1.28 | 66.96 | |
38 | Current Gene Therapy | journal | 0.674 Q2 | 80 | 33 | 114 | 3190 | 359 | 106 | 3.41 | 96.67 | |
39 | Current Women's Health Reviews | journal | 0.157 Q4 | 16 | 67 | 181 | 3025 | 67 | 168 | 0.39 | 45.15 | |
40 | Current Neurovascular Research | journal | 0.461 Q3 | 60 | 53 | 207 | 2942 | 435 | 192 | 1.80 | 55.51 | |
41 | Current Vascular Pharmacology | journal | 0.991 Q1 | 69 | 47 | 196 | 2887 | 702 | 154 | 2.23 | 61.43 | |
42 | Current Drug Safety | journal | 0.352 Q3 | 41 | 83 | 127 | 2789 | 177 | 124 | 1.10 | 33.60 | |
43 | Current Rheumatology Reviews | journal | 0.384 Q3 | 29 | 63 | 154 | 2741 | 184 | 149 | 1.11 | 43.51 | |
44 | Current Cancer Therapy Reviews | journal | 0.172 Q4 | 17 | 30 | 100 | 2663 | 61 | 93 | 0.44 | 88.77 | |
45 | Current Drug Discovery Technologies | journal | 0.319 Q3 | 49 | 43 | 184 | 2498 | 326 | 180 | 1.82 | 58.09 | |
46 | Nanoscience and Nanotechnology - Asia | journal | 0.180 Q4 | 17 | 41 | 200 | 2494 | 182 | 189 | 1.06 | 60.83 | |
47 | Recent Patents on Nanotechnology | journal | 0.364 Q2 | 36 | 33 | 86 | 2461 | 208 | 80 | 2.13 | 74.58 | |
48 | Current Drug Therapy | journal | 0.171 Q3 | 20 | 38 | 128 | 2424 | 87 | 124 | 0.40 | 63.79 | |
49 | Anti-Infective Agents | journal | 0.178 Q4 | 26 | 38 | 152 | 2338 | 114 | 146 | 0.61 | 61.53 | |
50 | Recent Patents on Biotechnology | journal | 0.277 Q3 | 42 | 26 | 75 | 2019 | 117 | 70 | 1.29 | 77.65 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®